Published in Antimicrob Agents Chemother on April 01, 1992
Campylobacter enteritis: a "new" disease. Br Med J (1977) 34.77
Campylobacter enteritis. Clin Gastroenterol (1979) 18.67
Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med (1979) 12.90
Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol (1991) 6.16
A selective medium for isolating Campylobacter jejuni/coli. J Clin Pathol (1982) 5.59
Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23
Effect of several components of anaerobic incubation on antibiotic susceptibility test results. Antimicrob Agents Chemother (1972) 3.29
Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol (1985) 3.00
DNA relatedness and biochemical features of Campylobacter spp. isolated in central and South Australia. J Clin Microbiol (1985) 2.96
Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci. Ann Inst Pasteur Microbiol (1986) 2.92
Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79
Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother (1980) 2.71
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol (1987) 2.59
Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States. J Clin Microbiol (1989) 2.52
Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother (1984) 2.43
Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother (1981) 2.43
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness. J Clin Microbiol (1991) 2.15
Campylobacter laridis causing bacteremia in an immunosuppressed patient. Ann Intern Med (1984) 2.14
Development of a blood-free Campylobacter medium: screening tests on basal media and supplements, and the ability of selected supplements to facilitate aerotolerance. J Appl Bacteriol (1983) 1.94
Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels. Antimicrob Agents Chemother (1982) 1.88
In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother (1985) 1.88
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media. J Clin Microbiol (1985) 1.65
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors. Antimicrob Agents Chemother (1985) 1.61
Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother (1985) 1.60
Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J Antimicrob Chemother (1986) 1.57
Isolation of Campylobacter jejuni from raw milk. Appl Environ Microbiol (1983) 1.55
Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother (1983) 1.53
Antimicrobial susceptibility of Campylobacter jejuni isolated from humans with diarrhoea and from healthy chickens. J Antimicrob Chemother (1981) 1.42
Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob Agents Chemother (1987) 1.34
Enteritis associated with Campylobacter laridis. J Clin Microbiol (1987) 1.29
In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother (1985) 1.29
Laboratory and clinical evaluation of isolation media for Campylobacter jejuni. J Clin Microbiol (1987) 1.28
Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents. Pathology (1983) 1.18
In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs. Antimicrob Agents Chemother (1985) 1.17
Macrolide, lincosamide and streptogramin resistance in Campylobacter jejuni/coli. J Antimicrob Chemother (1986) 1.13
Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid. J Clin Microbiol (1987) 1.08
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother (1987) 1.06
Characterization of freshly isolated Campylobacter coli strains and suitability of selective media for their growth. J Clin Microbiol (1988) 1.05
Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agents. Diagn Microbiol Infect Dis (1988) 0.97
In vitro evaluation of antibiotics for treatment of meningitis caused by Campylobacter fetus subspecies fetus. Pediatr Infect Dis J (1989) 0.96
The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection (1987) 0.85
Comparative efficacy of seven selective media for isolating Campylobacter jejuni. J Clin Microbiol (1986) 0.85
Antibiotic sensitivity patterns of Campylobacter jejuni/coli isolated from laboratory animals and pets. Lab Anim Sci (1984) 0.83
In-vitro evaluation of antibiotic combinations against Campylobacter fetus. J Antimicrob Chemother (1989) 0.82
[Sensitivity of Campylobacter jejuni/coli to 11 antibiotics]. Pathol Biol (Paris) (1984) 0.82
Isolation of Campylobacter fetus ss jejuni in adult patients with diarrheal syndrome. Arch Invest Med (Mex) (1985) 0.76
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23
Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol (1976) 7.48
Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun (1993) 6.72
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains. Antimicrob Agents Chemother (1980) 5.37
Isolation of Escherichia coli O157:H7 from dairy cattle associated with two cases of haemolytic uraemic syndrome. Lancet (1986) 4.44
Toward a population genetic analysis of Salmonella: genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimurium. Proc Natl Acad Sci U S A (1988) 4.43
Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1988) 4.12
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting. N Engl J Med (1982) 4.03
The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis (1986) 3.96
Effect of temperature on the in vitro susceptibility of Staphylococcus aureus to penicillinase-resistant penicillins. Antimicrob Agents Chemother (1973) 3.89
Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol (1979) 3.86
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53
Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks. J Clin Microbiol (1984) 3.33
Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother (1975) 3.32
Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol (1994) 3.27
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis (1991) 3.12
In vitro activity of antimicrobial agents on Legionnaires disease bacterium. Antimicrob Agents Chemother (1978) 3.11
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol (1993) 3.01
Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Infect Immun (1988) 2.99
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol (1983) 2.96
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
Micro antistreptolysin O test. Appl Microbiol (1968) 2.90
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System. J Clin Microbiol (1983) 2.71
Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J Infect Dis (1992) 2.62
Evaluation of the MicroScan antimicrobial susceptibility system with the autoSCAN-4 automated reader. J Clin Microbiol (1986) 2.60
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol (1987) 2.59
In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains. J Antimicrob Chemother (1979) 2.55
Parasitic, bacterial, and viral enteric pathogens associated with diarrhea in the Central African Republic. J Clin Microbiol (1984) 2.46
Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol (1992) 2.45
Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis. J Clin Microbiol (1987) 2.44
Antimicrobial susceptibility of Streptococcus mutans isolated from patients with endocarditis. Antimicrob Agents Chemother (1974) 2.37
Serotype-specific prevalence of Escherichia coli strains with EPEC adherence factor genes in infants with and without diarrhea in São Paulo, Brazil. J Infect Dis (1989) 2.35
Micro test for streptococcal anti-deoxyribonuclease B. Appl Microbiol (1969) 2.33
Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbiol (1985) 2.26
Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother (1979) 2.17
Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness. J Clin Microbiol (1991) 2.15
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Aeromonas intestinal infections in the United States. Ann Intern Med (1986) 2.03
Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med (1994) 2.01
Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J Clin Microbiol (1993) 1.97
Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins. Antimicrob Agents Chemother (1976) 1.93
"Upper limits of normal" antistreptolysin O and antideoxyribonuclease B titers. Appl Microbiol (1971) 1.91
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med (1989) 1.89
Difference between toxigenic Vibrio cholerae O1 from South America and US gulf coast. Lancet (1991) 1.87
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates. J Clin Microbiol (1992) 1.86
Molecular epidemiology of Yersinia enterocolitica O:3 infections: use of chromosomal DNA restriction fragment length polymorphisms of rRNA genes. J Clin Microbiol (1991) 1.80
Isolation of Latin American epidemic strain of Vibrio cholerae O1 from US Gulf Coast. Lancet (1992) 1.80
Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun (1990) 1.80
Restriction fragment length polymorphisms in the ribosomal genes for species identification and subtyping of aerotolerant Campylobacter species. J Clin Microbiol (1991) 1.77
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Relationship between in vitro susceptibility test results for chloramphenicol and production of chloramphenicol acetyltransferase by Haemophilus influenzae, Streptococcus pneumoniae, and Aerococcus species. J Clin Microbiol (1988) 1.75
autoSCAN-4 system for identification of gram-negative bacilli. J Clin Microbiol (1985) 1.73
Piperacillin susceptibility tests by the single-disk agar diffusion technique. Antimicrob Agents Chemother (1979) 1.73
Vibriophage VcA-3 as an epidemic strain marker for the U.S. Gulf Coast Vibrio cholerae O1 clone. J Clin Microbiol (1992) 1.68
Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J Clin Microbiol (1996) 1.68
Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate. Antimicrob Agents Chemother (1978) 1.67
Plasmid-mediated properties of a heat-stable enterotoxin-producing Escherichia coli associated with infantile diarrhea. Infect Immun (1976) 1.67
Restriction fragment length polymorphisms in rRNA operons for subtyping Shigella sonnei. J Clin Microbiol (1991) 1.63
Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animals. J Clin Microbiol (1995) 1.62
Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J Clin Microbiol (1990) 1.60
Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet (1982) 1.57
Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol (1996) 1.48
Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet (1988) 1.46
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis. J Clin Microbiol (1984) 1.41
Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J Clin Microbiol (1993) 1.41
Campylobacter isolates in the United States, 1982-1986. MMWR CDC Surveill Summ (1988) 1.40
Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II. J Clin Microbiol (1989) 1.35
Ureolytic Escherichia coli of human origin: serological, epidemiological, and genetic analysis. J Clin Microbiol (1979) 1.35
Meningococcal disease in the United States--1986. Meningococcal Disease Study Group. J Infect Dis (1991) 1.34
Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping). J Infect Dis (1992) 1.33
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
DNA probe analysis of diarrhoeagenic Escherichia coli: detection of EAF-positive isolates of traditional enteropathogenic E. coli serotypes among Bangladeshi paediatric diarrhoea patients. Mol Cell Probes (1992) 1.32
Plesiomonas enteric infections in the United States. Ann Intern Med (1986) 1.32
Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother (1981) 1.28
The emerging diversity of the electrophoretic types of Vibrio cholerae in the Western Hemisphere. J Infect Dis (1995) 1.28
Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun (1989) 1.27
Nosocomial meningitis due to Citrobacter diversus in neonates: new aspects of the epidemiology. J Infect Dis (1984) 1.26
Serotype, antimicrobial resistance, and adherence properties of Escherichia coli strains associated with outbreaks of diarrheal illness in children in the United States. J Clin Microbiol (1989) 1.25
Hemolytic activity in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli. J Clin Microbiol (1980) 1.25
Pyrazinamidase, CR-MOX agar, salicin fermentation-esculin hydrolysis, and D-xylose fermentation for identifying pathogenic serotypes of Yersinia enterocolitica. J Clin Microbiol (1992) 1.24
Comparison of plasmid profiles, phage types, and antimicrobial resistance patterns of Salmonella enteritidis isolates in the United States. J Clin Microbiol (1992) 1.23
Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. J Infect Dis (1989) 1.20
Cholera after the consumption of raw oysters. A case report. Ann Intern Med (1987) 1.17
Characterization of Shigella dysenteriae serotypes 11, 12, and 13. J Clin Microbiol (1990) 1.16
Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. Antimicrob Agents Chemother (1980) 1.15
Genetic probes for enterotoxigenic Escherichia coli isolated from childhood diarrhea in the Central African Republic. J Clin Microbiol (1983) 1.15
A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol (2000) 1.10
In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuni. J Clin Microbiol (1985) 1.09
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Antimicrob Agents Chemother (1980) 1.04
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol (1992) 1.04
Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins. J Clin Microbiol (1983) 1.04
Arcobacter (Campylobacter) butzleri-associated diarrheal illness in a nonhuman primate population. Infect Immun (1993) 1.00